The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Cash Flow from Investing : BDT0.00 Mil (TTM As of . 20)

The IBN SINA Pharmaceutical Industry Cash Flow from Investing Chart

The IBN SINA Pharmaceutical Industry Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

The IBN SINA Pharmaceutical Industry's Cash Flow from Investing for the fiscal year that ended in . 20 is calculated as:

The IBN SINA Pharmaceutical Industry's Cash Flow from Investing for the quarter that ended in . 20 is calculated as:

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow from Investing for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

The IBN SINA Pharmaceutical Industry's purchase of property, plant, equipment for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry spent BDT0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

The IBN SINA Pharmaceutical Industry's sale of property, plant, equipment for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry gained BDT0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

The IBN SINA Pharmaceutical Industry's purchase of business for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry spent BDT0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

The IBN SINA Pharmaceutical Industry's sale of business for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry gained BDT0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

The IBN SINA Pharmaceutical Industry's purchase of investment for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

The IBN SINA Pharmaceutical Industry's sale of investment for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry gained BDT0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

The IBN SINA Pharmaceutical Industry's net Intangibles purchase and sale for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry paid BDT0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

The IBN SINA Pharmaceutical Industry's cash from discontinued investing activities for the six months ended in . 20 was 0.00 Mil. It means The IBN SINA Pharmaceutical Industry paid BDT0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

The IBN SINA Pharmaceutical Industry's cash from other investing activities for the six months ended in . 20 was BDT0.00 Mil. It means The IBN SINA Pharmaceutical Industry paid BDT0.00 Mil for other investing activities.

The IBN SINA Pharmaceutical Industry Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description